08.06.2015 Views

Abstracts - Association for Chemoreception Sciences

Abstracts - Association for Chemoreception Sciences

Abstracts - Association for Chemoreception Sciences

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

P O S T E R S<br />

#P322 POSTER SESSION VII:<br />

OLFACTORY PSYCHOPHYSICS &<br />

CLINICAL STUDIES; CENTRAL OLFACTION<br />

Investigation of detection and pain thresholds at different sites<br />

at the human nasal mucosa in healthy subjects and patients<br />

with chronic rhinosinusitis<br />

Mandy Scheibe, Annika Schmidt<br />

Ent Department Dresden, Germany<br />

Background: Previous investigations in humans suggest<br />

topographical differences in the arrangement of intranasal<br />

trigeminal chemosensitivity with the highest sensitivity in the<br />

anterior part of the nasal cavity. The aim of the present study<br />

was to investigate if different sites at the human nasal mucosa<br />

react differently to unspecific electrical stimuli and if there are<br />

differences in healthy subjects and patients. Material and<br />

Methods: A total of 50 young, healthy volunteers (24 men,<br />

26 women; age 22-38 years) and 10 patients with nasal polyps<br />

prior sinus surgery (6 men, 4 women; age 19 - 43 years)<br />

participated. Detection and pain threshold of trigeminal stimuli of<br />

the healthy subjects and the patients were investigated at 5<br />

different sites at the nasal mucosa: anterior septum, posterior<br />

septum, lower turbinate, middle turbinate and anterior lateral<br />

nasal wall. Electrical stimuli were applied with a spherical<br />

electrode. Results: In healthy subjects a significantly higher<br />

trigeminal sensitivity was found at the anterior parts of the nose<br />

compared to the posterior part. There was a similar distribution<br />

pattern of the sensitivity <strong>for</strong> detection and pain thresholds. In<br />

patients there was a higher detection thresholds compared to<br />

healthy subjects, interestingly. Conclusions: The present data<br />

suggest that there are topographical differences in the arrangement<br />

of trigeminal neurons at the human nasal cavity. The highest<br />

sensitivity seems to be located in the anterior part of the nasal<br />

cavity. This finding is compatible with the idea that the trigeminal<br />

system acts as a sentinel of the human airways with regard to toxic<br />

agents. In case of the patients with chronic rhinosinusitis the<br />

sensitivity of the nasal mucosa seems to be reduced which may<br />

contribute to the sensation of a “congested nose”.<br />

#P323 POSTER SESSION VII:<br />

OLFACTORY PSYCHOPHYSICS &<br />

CLINICAL STUDIES; CENTRAL OLFACTION<br />

Odors, Asthma and Risk Perception<br />

Cristina Jaen, Pamela H. Dalton<br />

Monell Chemical Senses Center Philadelphia, PA, USA<br />

Fragrances and strong odors have been characterized as a putative<br />

trigger that may exacerbate asthma symptoms and many<br />

asthmatics readily avoid odors and fragranced products. However,<br />

the mechanism by which exposure to pure odorants can elicit an<br />

adverse reaction in asthmatic patients is still unclear and may<br />

involve both physiological and psychological processes. The aim<br />

of this study was to investigate how beliefs about an odor’s<br />

relationship to asthmatic symptoms could affect the physiological<br />

and psychological responses of asthmatics. Asthmatics classified<br />

as ‘moderate-persistent’, according to NIH criteria, were exposed<br />

<strong>for</strong> 15 minutes to a fragrance which was described either as<br />

eliciting or alleviating asthma symptoms. During exposure,<br />

participants were asked to rate odor intensity, perceived irritation<br />

and subjective annoyance while physiological parameters such as<br />

electrocardiogram, respiratory rate, and end tidal carbon dioxide<br />

(EtCO2) were recorded. Be<strong>for</strong>e, immediately after, and at 2 and 24<br />

hours post-exposure, participants were required to subjectively<br />

assess their asthma symptom status using a standardized<br />

questionnaire. We also measured asthma status at each of those<br />

time points using objective parameters of bronchoconstriction<br />

(spirometry) and measures of airway inflammation (exhaled nitric<br />

oxide -eNO). Predictably, manipulations of perceived risk altered<br />

both the quality ratings of the fragrance as well as the reported<br />

levels of asthma symptoms. However, perceived risk also<br />

appeared to modulate the inflammatory airway response,<br />

suggesting that stress elicited by the instructions may affect<br />

airway physiology and impact asthma exacerbations.<br />

Acknowledgements: Supported by NIH-NIDCD grant number<br />

RO1 DC 003704 to PD.<br />

#P324 POSTER SESSION VII:<br />

OLFACTORY PSYCHOPHYSICS &<br />

CLINICAL STUDIES; CENTRAL OLFACTION<br />

“Olfaction in Burning Mouth Syndrome”<br />

Yuri L. Yakov, Svetlana Yakov, Alan R. Hirsch<br />

Smell &Taste Treatment and Research Foundation Chicago, IL,<br />

USA<br />

Objective: While Burning Mouth Syndrome (BMS) has been<br />

linked to disorders of taste, a <strong>for</strong>mal assessment of olfaction has<br />

not been entertained. Background: BMS is a condition of chronic<br />

neuropathic pain affecting the tongue and other intraoral<br />

structures in more then one million Americans. Methods:<br />

Retrospective chart review of the most recent 22 BMS patients<br />

(7 males, 15 females) was assessed <strong>for</strong> olfactory complaints and<br />

testing. Results: Average age was 59 years (males) and 54 years<br />

(females), the severity of burning on a scale of 1 to 10 was 7. Fifty<br />

five percent of patients (12 out of 22) had at least one olfactory<br />

complaint as follows: hyposmia - 55%, dysosmia – 23%, and<br />

phantosmia – 14%. Twenty patients (90%) who per<strong>for</strong>med<br />

olfactory tests had abnormal results bilaterally. Forty one percent<br />

of these patients had 1 test abnormal, 9% of these patients – 2<br />

tests, 27% - 3 tests and 14% - 4 tests abnormal. Of those who<br />

per<strong>for</strong>med the Brief Smell Identification Test corrected <strong>for</strong> age and<br />

sex - 4 out of 9 (44 %) had abnormal results; Alcohol<br />

Suprathreshold Testing – 11 out of 14 (79%); Smell Threshold<br />

Test with phenyl ethyl alcohol – 8 out of 10 (80%) patients had<br />

abnormal results in both nostrils tested individually; Quick Smell<br />

Identification Test - 9 out of 19 (47%); the Pocket Smell Test – 6<br />

out 16 (38%); the unilateral University of Pennsylvania Smell<br />

Identification Test corrected <strong>for</strong> age and sex – 5 out of 7 (71%)<br />

patients had abnormal results in both nostrils tested individually.<br />

The incidence of chemosensory complaints in the general<br />

population is approximately 5%, whereas the incidence of<br />

chemosensory complaints and dysfunction in those with BMS was<br />

far greater (55%). Conclusion: Beside taste dysfunction, BMS<br />

may manifest as a generalized chemosensory disorder.<br />

134 | AChemS <strong>Abstracts</strong> 2010<br />

<strong>Abstracts</strong> are printed as submitted by the author(s)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!